Signatur Biosciences raises €450K Pre-Seed round
1 January 2022· London, United Kingdom· health, biotechnology, molecular_diagnostics, diagnostic_testing, software_hardware, b2b
This funding typically supports early-stage development, validation of technology, and participation in the accelerator program to scale the startup.
Investors
LeadY Combinator
About Signatur Biosciences
Stage
Seed
Headquarters
London, United Kingdom
Founded
2022
Team Size
6–20
Sectors
healthbiotechnologymolecular_diagnosticsdiagnostic_testingsoftware_hardwareb2b